Literature DB >> 28692026

Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II-IV acute GvHD: a systematic review and meta-analysis.

A Rashidi1, D Weisdorf1.   

Abstract

Acute GvHD (aGvHD) complicates up to 50% of allogeneic hematopoietic cell transplants and pre-transplant estimation of its risk can guide prophylaxis, monitoring and early intervention strategies. Inspired by the role of tumor necrosis factor alpha (TNFα) in the pathogenesis of aGvHD and the inconsistency of the association studies exploring single nucleotide polymorphisms (SNPs) of the TNF gene, we conducted a systematic review and meta-analysis of the available reports using PubMed and EMBASE. Original human studies reporting on the association between recipient TNF SNPs and grade II-IV aGvHD in a format convertible to effect size and confidence interval were included. One of the two most widely investigated SNPs (rs361525G>A) was marginally associated with increased risk of grade II-IV aGvHD in random-effects meta-analysis of six studies (627 patients in total, risk ratio=1.29, 95% confidence interval=0.99-1.69, P=0.06). If this result is validated in a large cohort with uniform conditioning and GvHD prophylaxis, TNF rs361525G>A may become a useful tool for aGvHD risk estimation before the transplant.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28692026     DOI: 10.1038/bmt.2017.144

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  31 in total

1.  Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

Authors:  P Hervé; M Flesch; P Tiberghien; J Wijdenes; E Racadot; P Bordigoni; E Plouvier; J L Stephan; H Bourdeau; E Holler
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

2.  Production of TNF-α and IL-1β by peripheral blood mononuclear cells in carriers of different allele variants of the gene.

Authors:  A N Silkov; N S Sennikova; E P Goreva; Yu A Lopatnikova; S V Sennikov
Journal:  Bull Exp Biol Med       Date:  2012-05       Impact factor: 0.804

Review 3.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

Review 4.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

7.  Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  G Socié; P Loiseau; R Tamouza; A Janin; M Busson; E Gluckman; D Charron
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

8.  Influence of TNFalpha gene polymorphisms on TNFalpha production and disease.

Authors:  A H Hajeer; I V Hutchinson
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

9.  Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.

Authors:  Charles Mullighan; Sue Heatley; Kathleen Doherty; Ferenc Szabo; Andrew Grigg; Timothy Hughes; Anthony Schwarer; Jeff Szer; Brian Tait; Bik To; Peter Bardy
Journal:  Transplantation       Date:  2004-02-27       Impact factor: 4.939

10.  Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

Authors:  Stephen Spellman; Melissa B Warden; Michael Haagenson; Bradley C Pietz; Els Goulmy; Edus H Warren; Tao Wang; Thomas M Ellis
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

View more
  2 in total

1.  Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.

Authors:  Armin Rashidi; Ryan Shanley; Sophia L Yohe; Bharat Thyagarajan; Julie Curtsinger; Claudio Anasetti; Edmund K Waller; Jeffrey S Miller; Bruce R Blazar; Daniel J Weisdorf
Journal:  Bone Marrow Transplant       Date:  2018-03-07       Impact factor: 5.483

Review 2.  Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?

Authors:  Xiao-Su Zhao; Xiao-Jun Huang
Journal:  Biomark Res       Date:  2019-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.